MENU
NXTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NextCure (NXTC) Earnings Date & Reports
NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
NXTC is expected to report earnings to fall 67.86% to -89 cents per share on November 04
Q3'26
Est.
$-0.90
Q2'26
Missed
by $0.89
Q1'26
Missed
by $1.42
Q4'25
Missed
by $1.89
Q3'25
Missed
by $2.77
The last earnings report on August 06 showed earnings per share of -279 cents, missing the estimate of -190 cents. With 25.63K shares outstanding, the current market capitalization sits at 24.79M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases
Industry Biotechnology
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
40
Web
https://www.nextcure.com